JRC News

  1. 15 Jan 2016

    The JOPRAD Regional Meeting (3rd-4th February 2016) aims to prepare countries' conditions for potential Joint Programming on Radioactive Waste Disposal.

  2. 14 Jan 2016

    The Border Monitoring Working Group (BMWG - JRC-IAEA-USA Nuclear Security Collaboration) celebrated its 10 years anniversary on the 2nd-3rd of December in Brussels hosted by the European Commission Joint Research Centre.

  3. 13 Jan 2016

    In the run-up to the 2016 Nuclear Security Summit, the JRC and the US Department of State (DoS) will be co-hosting the 2016 Counter Nuclear Smuggling (CNS) Workshop in Karlsruhe, Germany.

  4. 21 Dec 2015

    Targeted alpha therapy has the potential to selectively eliminate HIV infected cells from the central nervous system, according to a recent study co-authored by the JRC.

  5. 11 Dec 2015

    Additional efforts to further enhance the EU's extensive know-how and attract more young people to studies and training in nuclear related disciplines are needed for nuclear decommissioning.

  6. 30 Oct 2015

    Six road and railway border crossings with Uzbekistan and Afghanistan are now equipped with radiation portal monitors, supported by a mobile laboratory, which will allow customs authorities to detect radioactive materials.

  7. 18 Oct 2015

    Setting up a long-term strategy beyond existing EU policies, addressing governance of its expanding function and stepping up interaction with the scientific community across the EU are the main recommendations, stemming from an independent panel of experts' evaluation.

  8. 14 Oct 2015

    The World Standards Day, celebrated internationally on 14 October, was designed to raise awareness on the importance of standardisation to the global economy.

  9. 2 Oct 2015

    A JRC invention initially stemming from its research in the nuclear sector will soon be used by hospitals for minimally-invasive robotic surgery.

  10. 23 Sep 2015

    A novel, accelerator-driven method could produce nuclides for targeted alpha therapy of cancer in practically unlimited amounts, overcoming current obstacles for its wider use due to a limited production of alpha-emitters.